These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 27102854)

  • 1. Economic Approaches to Estimating Benefits of Regulations Affecting Addictive Goods.
    Cutler DM; Jessup AI; Kenkel DS; Starr MA
    Am J Prev Med; 2016 May; 50(5 Suppl 1):S20-S26. PubMed ID: 27102854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-benefit analysis involving addictive goods: contingent valuation to estimate willingness-to-pay for smoking cessation.
    Weimer DL; Vining AR; Thomas RK
    Health Econ; 2009 Feb; 18(2):181-202. PubMed ID: 18566968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic man and the consumption of addictive goods: the case of two goods.
    Andersson L; Bask M; Melkersson M
    Subst Use Misuse; 2006; 41(4):453-66. PubMed ID: 16522558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The consequences of tobacco tax on household health and finances in rich and poor smokers in China: an extended cost-effectiveness analysis.
    Verguet S; Gauvreau CL; Mishra S; MacLennan M; Murphy SM; Brouwer ED; Nugent RA; Zhao K; Jha P; Jamison DT
    Lancet Glob Health; 2015 Apr; 3(4):e206-16. PubMed ID: 25772692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking kills: An economic theory of addiction, health deficit accumulation, and longevity.
    Strulik H
    J Health Econ; 2018 Nov; 62():1-12. PubMed ID: 30261429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modelling a two-tier tobacco excise tax policy to reduce smoking by focusing on the addictive component (nicotine) more than the tobacco weight.
    Laugesen M
    N Z Med J; 2012 Dec; 125(1367):35-48. PubMed ID: 23321882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjustment costs, withdrawal effects, and cigarette addiction.
    Jones AM
    J Health Econ; 1999 Jan; 18(1):125-37. PubMed ID: 10338818
    [No Abstract]   [Full Text] [Related]  

  • 8. Does smuggling negate the impact of a tobacco tax increase?
    Tsui TC
    Tob Control; 2016 May; 25(3):361-2. PubMed ID: 26085122
    [No Abstract]   [Full Text] [Related]  

  • 9. Estimating the short-term clinical and economic benefits of smoking cessation: do we have it right?
    Menzin J; Lines LM; Marton J
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):257-64. PubMed ID: 19527098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demand analysis of tobacco consumption in Malaysia.
    Ross H; Al-Sadat NA
    Nicotine Tob Res; 2007 Nov; 9(11):1163-9. PubMed ID: 17978990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling the implications of regular increases in tobacco taxation in the tobacco endgame.
    Cobiac LJ; Ikeda T; Nghiem N; Blakely T; Wilson N
    Tob Control; 2015 Jun; 24(e2):e154-60. PubMed ID: 25145342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of varenicline versus bupropion, nicotine-replacement therapy, and unaided cessation in Greece.
    Athanasakis K; Igoumenidis M; Karampli E; Vitsou E; Sykara G; Kyriopoulos J
    Clin Ther; 2012 Aug; 34(8):1803-14. PubMed ID: 22818870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual cigarette consumption and addiction: a flexible limited dependent variable approach.
    Yen ST; Jones AM
    Health Econ; 1996; 5(2):105-17. PubMed ID: 8733103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a microsimulation economic model to evaluate the disease burden associated with smoking and the cost-effectiveness of tobacco control interventions in Latin America.
    Pichon-Riviere A; Augustovski F; Bardach A; Colantonio L;
    Value Health; 2011; 14(5 Suppl 1):S51-9. PubMed ID: 21839900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness Analysis of Smoking Cessation Interventions in Japan Using a Discrete-Event Simulation.
    Igarashi A; Goto R; Suwa K; Yoshikawa R; Ward AJ; Moller J
    Appl Health Econ Health Policy; 2016 Feb; 14(1):77-87. PubMed ID: 26597111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do consumers of manufactured cigarettes respond differently to price changes compared with their Roll-Your-Own counterparts? Evidence from New Zealand.
    Tait P; Rutherford P; Saunders C
    Tob Control; 2015 May; 24(3):285-9. PubMed ID: 24259046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Environmental influences on tobacco use: evidence from societal and community influences on tobacco use and dependence.
    Cummings KM; Fong GT; Borland R
    Annu Rev Clin Psychol; 2009; 5():433-58. PubMed ID: 19327036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Price and trade: World No Tobacco Day 2015.
    Rimmer M
    Tob Control; 2015 Jun; 24(e2):e123-4. PubMed ID: 26025095
    [No Abstract]   [Full Text] [Related]  

  • 19. Addiction surplus: the add-on margin that makes addictive consumptions difficult to contain.
    Adams PJ; Livingstone C
    Int J Drug Policy; 2015 Jan; 26(1):107-11. PubMed ID: 25175598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The recent and projected public health and economic benefits of cigarette taxation in Greece.
    Alpert HR; Vardavas CI; Chaloupka FJ; Vozikis A; Athanasakis K; Kyriopoulos I; Bertic M; Behrakis PK; Connolly GN
    Tob Control; 2014 Sep; 23(5):452-4. PubMed ID: 23467654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.